Compare Eaton Corporation plc (ETN) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Johnson & Johnson — how do they compare? Eaton Corporation plc trades at $430 (market cap $164.88B), while Johnson & Johnson trades at $261.43 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 3.7× Eaton Corporation plc's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Johnson & Johnson for 129 Days on average.
| ETN | JNJ | |
|---|---|---|
Market Cap | $164.88B | $618.09B |
Volume | 2,535,086 | 6,050,983 |
Sector | Industrials | Health |
52-Week High | $459.96 | $278.43 |
52-Week Low | $315.82 | $186.00 |
Typical Hold Time | 31 Days | 129 Days |
Enterprise Value | $185.51B | $646.37B |
Dividend Yield | 1.04% | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $429.65, down 0.39% on the day, with technical indicators showing a bearish bias despite recent earnings beats. The company maintains strong fundamentals with 12.75% net income margin and 19.71% ROE, supported by strategic acquisitions in data center and aerospace markets. Analyst consensus remains strongly bullish with a $502.38 price target, representing 17% upside potential from current levels.
ETN's outlook remains positive driven by data center demand and grid modernization trends, though elevated valuation multiples (P/E 43.23) and bearish technical signals warrant caution. The stock faces execution risks from recent acquisitions and competitive pressure in the electrical equipment sector, but strong institutional support and consistent earnings performance support the bullish analyst stance.
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
